Is a negative lupus anticoagulant result with a PTT‑LA of 48 seconds and a dRVVT screen of 35 seconds normal, and what management is recommended?

Interpretation of Your Lupus Anticoagulant Results

Your results show a negative lupus anticoagulant (LA) by dRVVT criteria (screen ratio <1.2), but the prolonged PTT-LA of 48 seconds requires further evaluation with mixing and confirmatory studies before definitively ruling out LA.

Understanding Your Results

Your laboratory values show:

• PTT-LA: 48 seconds (prolonged - typically normal is <37-40 seconds depending on local reference ranges)
• dRVVT screen: 35 seconds (appears within normal limits based on typical ranges)
• LA interpretation: Negative

Why This Matters

The current ISTH guidance 1 mandates using two parallel tests - both dRVVT and an LA-sensitive APTT (your PTT-LA) - because omitting either test can miss up to 31% of APS patients 1. Your results show a discordant pattern that requires careful interpretation.

The Problem with Your Current Results

The prolonged PTT-LA of 48 seconds cannot be dismissed simply because the dRVVT screen is normal. Here's the algorithmic approach needed:

1. PTT-LA screening is prolonged (48 seconds vs normal ~35-40 seconds)

2. Next mandatory step: Perform a mixing study with normal pooled plasma

   • If the prolonged PTT-LA corrects with mixing → suggests factor deficiency, not LA
   • If the prolonged PTT-LA does NOT correct with mixing → proceed to confirmatory testing with phospholipid-rich reagent

3. If mixing study shows no correction: Perform PTT-LA confirmatory test

   • If confirmatory test shows correction (shortening) → LA is present
   • If confirmatory test shows no correction → suggests other inhibitor or interference

Critical Interpretation Issues

The dRVVT screen of 35 seconds alone doesn't tell us if LA is absent. Research shows that using a dRVVT ratio (screen/confirm) ≥1.2 is the appropriate cutoff 2, but you need the confirmatory test performed to calculate this ratio. A study demonstrated that 29% of patients with dRVVT screen ratios between 1.1-1.2 were actually LA positive 2.

Common pitfall: Many laboratories report "LA negative" based solely on screening tests without completing the full algorithm (screen → mix → confirm) as required by ISTH guidelines 1. This leads to false-negative results in up to 55% of triple-positive APS patients 1.

What Should Happen Next

Request the following from your laboratory:

1. PTT-LA mixing study - to determine if the prolongation corrects with normal plasma
2. PTT-LA confirmatory test - if mixing study shows incomplete correction
3. Calculate the normalized ratio for both tests using locally-derived cutoffs (not arbitrary values like 1.1) 3

The 2025 ISTH guidance emphasizes that "a situation of positive screening, negative mixing, and positive confirm step can only be picked up by performing the screen followed by simultaneous mix and confirm in all samples with a prolonged screening test" 1.

Clinical Context Matters

If you have any of these clinical features, LA testing becomes even more critical:

• History of unexplained thrombosis (venous or arterial)
• Recurrent pregnancy loss or adverse obstetric outcomes
• Connective tissue disease (especially SLE)
• Unexplained prolonged APTT on routine testing

Research shows LA-positive patients have 23% incidence of thrombosis compared to 13% in LA-negative patients 2, making accurate diagnosis essential for risk stratification.

Anticoagulation Interference

Critical caveat: If you are currently on anticoagulation (warfarin, DOACs, heparin), LA testing may be unreliable 1. The 2025 ISTH guidance discourages testing during anticoagulation due to high rates of false positives and false negatives 1. If testing must be done on anticoagulation, specialized interpretation by an expert is mandatory 4.

Management Recommendation

Do not accept "LA negative" as a final result with an isolated prolonged PTT-LA of 48 seconds. Contact the laboratory to:

1. Confirm that mixing and confirmatory studies were performed
2. Request the actual ratios and percentage corrections
3. Ensure locally-derived cutoffs (99th percentile from ≥40 healthy controls) were used 1

If LA is ultimately confirmed positive, repeat testing in 12 weeks is mandatory for APS diagnosis 1, as persistent positivity (not single positive test) defines clinically significant LA.

If the complete workup confirms LA is truly absent, investigate other causes of the prolonged PTT-LA including factor deficiencies (VIII, IX, XI, XII), von Willebrand disease, or other coagulation inhibitors.